Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Autonomic Disorders

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1657824

Comparative study of autonomic dysfunction between Parkinson's disease with LRRK2, PRKN, and GBA mutations

Provisionally accepted
  • 1Federal University of Rio Grande do Sul, Porto Alegre, Brazil
  • 2Universidade Federal de Ciencias da Saude de Porto Alegre, Porto Alegre, Brazil

The final, formatted version of the article will be published soon.

Background: Autonomic symptoms are among the most important factors determining the quality of life in patients with Parkinson’s disease (PD). This study aimed to assess the profile of autonomic dysfunction symptoms in three groups of patients with genetic PD, carrying mutations in GBA, LRRK2, and PRKN genes, compared with subjects with sporadic PD. Methods: This case-control observational secondary analysis of prospectively collected data was performed on 742 patients (485 in the sporadic group, 165 in the LRRK2 group, 85 in the GBA group, and nine in the PRKN group). Autonomic symptoms were evaluated using the Scale for Outcomes in Parkinson’s Disease-Autonomic (SCOPA-AUT). Results: The GBA group exhibited more severe autonomic linsymptoms than the sporadic group, even after controlling for potential confounders such as disease duration and levodopa equivalent daily dose (linear regression B value = −4.668; Total SCOPA-AUT: p=0.050; LEDD: p=0.966; Disease Duration: p=0.498). The LRRK2 group initially showed more autonomic symptoms, but this did not remain significant after adjustment for disease duration (B value = −3.105; p = 0.189). The PRKN group did not differ significantly from the sporadic group. Subgroup analysis highlighted specific issues including constipation, early satiety, and heat intolerance in both the GBA and LRRK2 groups, orthostatic hypotension in the GBA group and urinary incontinence and excessive perspiration in the LRRK2 group. Despite these subjective reports, objective assessment for orthostatic hypotension revealed no significant inter-group differences. Conclusion: These findings that genetic background may influence the severity of autonomic dysfunction in PD. In particular, patients with GBA mutations appear to experience a greater autonomic symptom burden, underscoring the need for personalized clinical monitoring and further research into genotype-specific disease progression. However, inconsistencies between subjective reports and objective autonomic measures emphasize the importance of employing more refined and sensitive assessment tools. Larger and demographically balanced cohorts are required to confirm these results, especially for the underpowered PRKN.

Keywords: dysautonomia, Parkinson's disease, SCOPA-AUT, genetic, autonomic Comentado [BD1]: Reviewer #2 -Request number 1 Comentado [BD2]: Reviewer #1 -Request number 3 Comentado [BD3]: Reviewer #1 -Request number 1

Received: 01 Jul 2025; Accepted: 04 Aug 2025.

Copyright: © 2025 Maldotti Dalla Corte, Medeiros Soares, Gomes de Carvalho Neto and Rieder. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Barbara Maldotti Dalla Corte, Federal University of Rio Grande do Sul, Porto Alegre, Brazil

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.